Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
AstraZeneca
Colorcon
Express Scripts
Baxter

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Torrent Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for TORRENT PHARMS, and what generic and branded alternatives to TORRENT PHARMS drugs are available?

TORRENT PHARMS has thirty-five approved drugs.

There are six tentative approvals on TORRENT PHARMS drugs.

Summary for Torrent Pharms
US Patents:0
Tradenames:30
Ingredients:29
NDAs:35

Drugs and US Patents for Torrent Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent Pharms DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 090686-002 May 31, 2011 AB RX No No   Start Trial   Start Trial
Torrent Pharms Ltd LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 091338-001 May 29, 2012 AB RX No No   Start Trial   Start Trial
Torrent Pharms Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 202170-001 Nov 28, 2011 AB RX No No   Start Trial   Start Trial
Torrent Pharms ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 200270-001 Jun 3, 2011 AB RX No No   Start Trial   Start Trial
Torrent Pharms RISPERIDONE risperidone TABLET;ORAL 079088-003 Oct 30, 2008 AB RX No No   Start Trial   Start Trial
Torrent Pharms Ltd OLANZAPINE olanzapine TABLET;ORAL 091434-003 Apr 23, 2012 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Colorcon
Moodys
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.